ALNYLAM PHARMACEUT earnings per share and revenue

DUL earnings per share for the last quarter are -0.74 CHF whereas the estimation was -0.78 CHF which accounts for 5.09% surprise. Company revenue for the same period amounts to 424.49 M CHF despite the estimated figure of 451.60 M CHF. Estimated earnings per share for the next quarter are -0.52 CHF, and revenue is expected to reach 514.93 M CHF. Also watch annual changes over time to get a bigger picture of DUL earnings per share and revenue dynamics.